An observational pharmacokinetic study of ceftolozane-tazobactam in intensive care unit patients with and without continuous renal replacement therapy (2016–2019)

Grant type:
Merck Sharp & Dohme Australia
  • NHMRC Leadership Fellow
    UQ Centre for Clinical Research
    Faculty of Medicine
    Director, UQ Centre for Clinical Re
    Faculty of Medicine
Funded by:
Merck, Sharp & Dohme